İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2024

4-h mean lactate clearance as a good predictor of adverse outcome in acute cardiogenic pulmonary edema: a pilot study

Turk J Biochem

YÖKSİS OpenAlex Açık erişim · gold SJR Q3 JCR Q4 TR Index Atıf 0 Yüzdelik 15.2% FWCI 0.0
Yıl
2024
ISSN
1303-829X
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

Abstract Objectives This pilot study aimed to evaluate the efficacy of the 4-h mean lactate clearance (LACclr) level as a predictive factor for in-hospital outcomes, 30-day mortality, and treatment success in patients with acute cardiogenic pulmonary edema (ACPE), a significant clinical form of acute heart failure (AHF). Methods A total of 44 patients diagnosed with acute pulmonary edema were included in the study. The patients were divided into two groups based on lactate levels and negative outcomes, and lactate and LACclr levels and negative outcomes were analyzed using statistical tests such as Fisher’s exact test, Student’s t-test, Mann-Whitney U test, and Receiver operating characteristic (ROC) analysis. Results The results indicated a statistically significant difference in the total hospitalization length of stay according to whether the patients had a negative outcome (intubation and in-hospital mortality) (p=0.033). Additionally, the area under the curve (AUC) value for 4-h mean LACclr was 0.795 in all patients, which was statistically significant in predicting 30-day mortality (p=0.033). The optimal cut-off value for the 4-h mean LACclr in predicting 30-day mortality was found to be 5.57 %, with 80 % sensitivity and 66.7 % specificity. The threshold to rule out 30-day mortality for all patients was 18.85 with 100 % sensitivity and 30.2 % specificity (AUC, 0.795 95 % CI [0.546–1.000], p=0.033). Conclusions These findings suggest that the 4-h LACclr level, calculated within 4 h of emergency department (ED) presentation, can be used as a predictive indicator for needing intubation, in-hospital mortality, and 30-day mortality and to identify patients at higher risk for adverse outcomes.

Konular

  • Heart Failure Treatment and Management
  • Hemodynamic Monitoring and Therapy
  • Pulmonary Hypertension Research and Treatments

Birincil konu Heart Failure Treatment and Management

Yazarlar

  1. ABDUSSAMED VURAL
  2. MAHMUT KARAPEHLİVAN
  3. TURGUT DOLANBAY
  4. MUSTAFA OĞUZ CUMAOĞLU
  5. AHMET YUNUS HATİP
  6. YAKUP ÇETİNKAYA
  7. ADNAN ÜNALAN NİĞDE ÖMER HALİSDEMİR ÜNİVERSİTESİ